HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masataka Sawaki Selected Research

Masataka Sawaki Research Topics

Disease

77Breast Neoplasms (Breast Cancer)
04/2024 - 01/2004
34Neoplasms (Cancer)
04/2024 - 01/2004
9Neoplasm Metastasis (Metastasis)
04/2023 - 01/2004
3Thrombocytopenia (Thrombopenia)
08/2022 - 04/2014
3Neutropenia
08/2022 - 04/2014
2Triple Negative Breast Neoplasms
04/2024 - 01/2021
2Diarrhea
06/2023 - 04/2014
2Cognitive Dysfunction
04/2022 - 08/2021
2Peripheral Nervous System Diseases (PNS Diseases)
05/2021 - 01/2006
2Ductal Carcinoma
09/2018 - 03/2016
2Margins of Excision
09/2016 - 07/2014
1Arthralgia (Joint Pain)
10/2023
1Interstitial Lung Diseases (Interstitial Lung Disease)
06/2022
1Cicatrix (Scar)
08/2021
1Anemia
01/2021
1Alopecia (Baldness)
11/2020
1Anorexia
11/2020
1Pneumothorax
07/2020
1Gastrointestinal Hemorrhage (Hematochezia)
07/2020
1Pathologic Complete Response
11/2019
1Stomatitis
10/2019
1Rare Diseases (Rare Disease)
02/2019
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2019
1Hemangiosarcoma (Angiosarcoma)
11/2018
1Dermatitis
11/2018
1Hand-Foot Syndrome
11/2018
1Residual Neoplasm
09/2018
1Disease Progression
01/2018
1Lobular Carcinoma
03/2016
1Febrile Neutropenia
03/2016
1Pain (Aches)
01/2016
1Spinal Cord Compression
01/2016

Drug/Important Bio-Agent (IBA)

18Trastuzumab (Herceptin)FDA Link
06/2023 - 01/2004
7Hormones (Hormone)IBA
01/2023 - 12/2013
7human ERBB2 proteinIBA
03/2022 - 01/2004
6ErbB Receptors (EGF Receptor)IBA
06/2023 - 05/2011
6Docetaxel (Taxotere)FDA Link
08/2021 - 01/2004
5Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2004
5pertuzumabIBA
08/2021 - 01/2014
4Estrogen ReceptorsIBA
04/2024 - 05/2019
4abemaciclibIBA
03/2023 - 01/2021
4Phenobarbital (Luminal)FDA Link
09/2021 - 10/2014
4Paclitaxel (Taxol)FDA LinkGeneric
05/2021 - 01/2004
3TeaIBA
01/2022 - 08/2021
3Ado-Trastuzumab EmtansineIBA
08/2021 - 01/2014
3Lapatinib (GW572016)FDA Link
04/2014 - 01/2014
2Cyclin-Dependent Kinase 4IBA
10/2023 - 08/2022
2palbociclibIBA
08/2023 - 06/2022
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2023 - 08/2022
2Bevacizumab (Avastin)FDA Link
06/2022 - 07/2020
2eribulinFDA Link
12/2021 - 06/2013
2Progesterone Receptors (Progesterone Receptor)IBA
05/2019 - 03/2019
2Estrogens (Estrogen)FDA Link
03/2019 - 01/2011
2ParaffinIBA
10/2014 - 01/2006
2Toremifene (Fareston)FDA Link
01/2012 - 01/2011
1Biomarkers (Surrogate Marker)IBA
04/2024
1trastuzumab deruxtecanIBA
03/2022
1AnthracyclinesIBA
12/2021
1taxaneIBA
12/2021
1Taxoids (Taxanes)IBA
12/2021
1entinostat (MS 275)IBA
11/2021
1exemestane (Aromasin)FDA Link
11/2021
1Histone Deacetylases (Histone Deacetylase)IBA
11/2021
1Epidermal Growth Factor (EGF)IBA
08/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1CreatinineIBA
01/2021
1PlasticsIBA
01/2020
1TOR Serine-Threonine KinasesIBA
10/2019
1SteroidsIBA
10/2019
1EverolimusFDA Link
10/2019
1Biological FactorsIBA
03/2019
1Amyloid (Amyloid Fibrils)IBA
02/2019
1Capecitabine (Xeloda)FDA Link
11/2018
1Vitamin B 6IBA
11/2018
1Pyridoxine (Pyridoxin)FDA LinkGeneric
11/2018
1UridineIBA
03/2016
1Glutathione S-Transferase piIBA
03/2016
1Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
03/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2016
1Epirubicin (Ellence)FDA LinkGeneric
03/2016
1Analgesics (Analgesic Drugs)IBA
01/2016
1Diphosphonates (Bisphosphonates)IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
04/2014

Therapy/Procedure

30Therapeutics
10/2023 - 01/2004
21Drug Therapy (Chemotherapy)
01/2024 - 01/2004
10Neoadjuvant Therapy
06/2023 - 08/2011
8Segmental Mastectomy (Lumpectomy)
04/2023 - 08/2011
7Radiotherapy
12/2019 - 12/2009
5Mammaplasty (Breast Reconstruction)
10/2023 - 09/2018
5Mastectomy (Mammectomy)
08/2021 - 09/2018
5Lymph Node Excision (Lymph Node Dissection)
07/2020 - 07/2011
3Adjuvant Chemotherapy
03/2022 - 11/2018
2Combination Drug Therapy (Combination Chemotherapy)
01/2006 - 01/2004
1Drug Tapering
08/2022
1Surgical Gloves (Surgical Glove)
05/2021
1Particle Accelerators
08/2019
1Operative Surgical Procedures
05/2019
1Complementary Therapies (Alternative Medicine)
01/2018
1Retreatment
01/2018
1Contraindications
07/2014